Drug resistance mechanism and reversal strategy in lung cancer immunotherapy

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy

Among all malignant tumors, lung cancer has the highest mortality and morbidity rates. The non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the most common histological subtypes. Although there are a number of internationally recognized lung cancer therapy regimens, their the...

Full description

Bibliographic Details
Main Authors: Yishi Xu, Yaqing Liu, Yi Ge, Haozhe Li, Yi Zhang, Liping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
lung cancer
immunotherapy
immune check inhibitor (ICI)
drug resistance
reversal strategy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1230824/full

Similar Items

Similar Items